H-G. Kopp
Publications by Year
Research Areas
Bariatric Surgery and Outcomes, Gastric Cancer Management and Outcomes, Cancer Research and Treatments, Lung Cancer Treatments and Mutations, Esophageal Cancer Research and Treatment
Most-Cited Works
- → Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients(2003)423 cited
- → Thrombin generation in morbid obesity: significant reduction after weight loss(2010)105 cited
- → Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications(1998)82 cited
- → Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer: Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)(2017)42 cited
- → Low Levels of Sex-Hormone-Binding Globulin predict insulin requirement in patients with gestational diabetes mellitus(2001)37 cited
- → Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial(2017)26 cited
- → Concentrations of circulating P-Selectin are increased in patients with newly diagnosed insulin-dependent diabetes mellitus(2009)17 cited
- → Erratum: Corrigendum: Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes(2006)6 cited
- → 1424MO Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma– Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM(2020)6 cited
- → Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin in advanced Non-Small Cell Lung Cancer (NSCLC) patient(2016)5 cited